Zhou Tao/Partner
T: 0755-2399 3388 F: 0755-8168 6205
zhoutao@grandwaylaw.com
Shenzhen,Beijing
-
Education background
LLB, Peking University
-
Areas of expertise
Securities and capital markets
M&A
Investment and finance
-
Membership
Member of the Law Firm Management and Cooperation Promotion Committee of Shenzhen Lawyers Association
-
Working Language
Chinese, English
Mr. Zhou Tao is serving for Grandway Law Offices as a partner and a convenor of internal control committee, and after graduation from Peking University, he has been deeply engaged in fields of securities and capital markets, M&A, and investment and finance for nearly 20 years.
During his practice of being a lawyer, Zhou has led and participated in IPO, refinance, M&A, restructuring, asset-backed securitization, and he has broad experience of and expertise in legal matters fields of FMCG, healthcare and pharmaceutical, high-tech and AI, new energy, semiconductor, new material, special equipment manufacturing,urban planning and design, Internet, and other industries.
With his outstanding professional performance and reputation among clients and peers, Zhou has been listed in the annual ranking of 2022 and 2023 and awarded as “Highly regarded” by the IFLR1000, listed in “2021 China Top 15 Lawyers - High-Tech & AI” “Top 15 Innovative Lawyers” and “2022 China Leading Lawyer” by the LEGALBAND, and “Top Ranked Lawyer - High-Tech” by the DAWKINS, and he has also been nominated as “Young Lawyer of the Year: South China & Central China - Non Local” in 2022 by the ALB.
- 2023.06.30Grandway Advised Biem.L.Fdlkk on Cross-border M&A of International Luxury Brands CERRUTI 1881 and Kent & Curwen
- 2023.05.30Grandway Advised Baobi New Energy on RMB 500 Million Series A Funding
- 2023.02.28Grandway Advised SEICHI on IPO Project Approved by the Listing Committee of SSE STAR Market
- 2023.02.28Grandway Advised Ligao Foods on Issuing Convertible Bonds to Unspecified Investors
- 2023.02.28Grandway Advised Shenling Environmental on the Issuance of Shares to Specific Investors
- 2023.02.28Grandway Advised Xinbao on Cross-border Acquisition of Morphy Brand and Related Assets
- 2023.01.17Grandway Advised PCI Technology on Its Non-public Offering Approved by Issuance Appraisal Committee of CSRC
- 2023.01.17Grandway Advised Kuncai Technology on Non-public offering Approved by Issuance Appraisal Committee of CSRC
- 2022.11.24Grandway Advised PCI Technology on Investing in Unity China, the Global “Metaverse” Leader
- 2022.11.24Grandway Advised Mankun Technology on Listing on the ChiNext of SZSE
- 2022.11.24Grandway Advised Tinci Materials on Public Offering of Convertible Bonds Approved by CSRC